pentobarbital will lower the level or result of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Use of different treatment options is strongly advised when linagliptin will be to be administered with a CYP3A4 inducerpentobarbital will minimize the extent or outcome of elbasvir/grazoprevir by influencing hepa